You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2014)

✉ Email this page to a colleague

« Back to Dashboard

Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2014)

Docket	⤷ Sign Up	Date Filed	2014-10-10
Court	District Court, D. Delaware	Date Terminated	2019-05-01
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	NOVARTIS AG
Patents	6,004,973; 6,239,124; 6,455,518
Attorneys	Michael P. Kelly
Link to Docket	External link to docket

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2014-10-10	1		United States Letters Patent No. 6,004,973 (“the ‘973 patent”). The ‘973 patent was duly and legally …United States Letters Patent No. 5,665,772 (“the ‘772 patent”). The ‘772 patent was duly and legally …United States Letters Patent No. 6,455,518 (“the ‘518 patent”). The ‘518 patent was duly and legally …the ‘772, ‘973, and ‘518 patents was an act of infringement of those patents. 23. … COMPLAINT FOR PATENT INFRINGEMENT filed against Par Pharmaceutical Inc. - Magistrate Consent Notice	External link to document
2016-09-26	149		of U.S. Patent No. 5,665,772 for Obviousness and the Invalidity of U.S. Patent Nos. 6,239,124 and 6,455,518…for Obviousness and for Obviousness-Type Double Patenting, by Par Pharmaceutical Inc.. (Fineman, Steven)…October 2014 1 May 2019 1:14-cv-01289 830 Patent None District Court, D. Delaware	External link to document
2016-10-17	156		Brief Regarding Noninfringement of U.S. Patent Nos. 6,239,124 and 6,455,518, by Par Pharmaceutical Inc…October 2014 1 May 2019 1:14-cv-01289 830 Patent None District Court, D. Delaware	External link to document
2016-10-25	161		Obviousness of U.S. Patent No. 5,665,772, and Invalidity of U.S. Patent Nos. 6,239,124 and 6,455,518, by…October 2014 1 May 2019 1:14-cv-01289 830 Patent None District Court, D. Delaware	External link to document
2017-05-16	180		FINAL JUDGMENT regarding U.S. Patent Nos. 5,665,772 and 6,455,518,. Signed by Judge Richard G. Andrews…October 2014 1 May 2019 1:14-cv-01289 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.